Behind the Scenes of Humana's Latest Options Trends

Whales with a lot of money to spend have taken a noticeably bearish stance on Humana.

Looking at options history for Humana HUM we detected 11 trades.

If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 45% with bearish.

From the overall spotted trades, 3 are puts, for a total amount of $136,443 and 8, calls, for a total amount of $489,765.

Latest Startup Investment Opportunities:

Predicted Price Range

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $270.0 to $340.0 for Humana over the last 3 months.

Volume & Open Interest Development

In today's trading context, the average open interest for options of Humana stands at 190.7, with a total volume reaching 1,036.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Humana, situated within the strike price corridor from $270.0 to $340.0, throughout the last 30 days.

Humana Option Volume And Open Interest Over Last 30 Days

Noteworthy Options Activity:

About Humana

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

In light of the recent options history for Humana, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Current Position of Humana

• With a volume of 837,701, the price of HUM is up 0.41% at $326.62.
• RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
• Next earnings are expected to be released in 1 days.

What Analysts Are Saying About Humana

In the last month, 5 experts released ratings on this stock with an average target price of $366.4.

• Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Humana, targeting a price of $385.
• An analyst from Barclays has decided to maintain their Equal-Weight rating on Humana, which currently sits at a price target of $310.
• An analyst from Cantor Fitzgerald has revised its rating downward to Neutral, adjusting the price target to $391.
• An analyst from Wells Fargo has decided to maintain their Overweight rating on Humana, which currently sits at a price target of $350.
• Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on Humana with a target price of $396.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Humana with Benzinga Pro for real-time alerts.